BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15487572)

  • 1. Unexpected toxicity following use of gemcitabine as a radiosensitizer in head and neck carcinomas: a veterinary radiation therapy oncology group pilot study.
    LeBlanc AK; LaDue TA; Turrel JM; Klein MK
    Vet Radiol Ultrasound; 2004; 45(5):466-70. PubMed ID: 15487572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine as a radiosensitizer for nonresectable feline oral squamous cell carcinoma.
    Jones PD; de Lorimier LP; Kitchell BE; Losonsky JM
    J Am Anim Hosp Assoc; 2003; 39(5):463-7. PubMed ID: 14518654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
    Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine concurrent with radiation therapy for locally advanced head and neck carcinomas.
    Chauhan A; Singh H; Sharma T; Manocha KK
    Afr Health Sci; 2008 Sep; 8(3):149-55. PubMed ID: 19357741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck.
    Aguilar-Ponce J; Granados-García M; Villavicencio V; Poitevin-Chacón A; Green D; Dueñas-González A; Herrera-Gómez A; Luna-Ortiz K; Alvarado A; Martínez-Said H; Castillo-Henkel C; Segura-Pacheco B; De la Garza J
    Ann Oncol; 2004 Feb; 15(2):301-6. PubMed ID: 14760126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study.
    Mohiuddin M; Kudrimoti M; Regine WF; McGrath PC; Hanna N; John W
    Cancer J; 2002; 8(3):255-62. PubMed ID: 12074325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.
    Vanderveken OM; Szturz P; Specenier P; Merlano MC; Benasso M; Van Gestel D; Wouters K; Van Laer C; Van den Weyngaert D; Peeters M; Vermorken J
    Oncologist; 2016 Jan; 21(1):59-71. PubMed ID: 26712958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Ali EM; Abdelraheem AG
    Head Neck Oncol; 2011 Nov; 3():48. PubMed ID: 22085617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine, cisplatin, and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study.
    Benasso M; Merlano M; Sanguineti G; Corvò R; Numico G; Ricci I; Pallestrini E; Santelli A; Vitale V; Marchetti G; Rosso R
    Am J Clin Oncol; 2001 Dec; 24(6):618-22. PubMed ID: 11801767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly gemcitabine and cisplatin in combination with radiotherapy in patients with locally advanced head-and-neck cancer: Phase I study.
    Viani GA; Afonso SL; Tavares VC; da Silva LG; Stefano EJ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e231-5. PubMed ID: 21570216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.
    Eisbruch A; Shewach DS; Bradford CR; Littles JF; Teknos TN; Chepeha DB; Marentette LJ; Terrell JE; Hogikyan ND; Dawson LA; Urba S; Wolf GT; Lawrence TS
    J Clin Oncol; 2001 Feb; 19(3):792-9. PubMed ID: 11157033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypofractionated radiation therapy for the treatment of malignant melanoma and squamous cell carcinoma in dogs and cats].
    Kinzel S; Hein S; Stopinski T; Koch J; Buecker A; Treusacher HP; Schmachtenberg A; Jansen T; Eble M; Küpper W
    Berl Munch Tierarztl Wochenschr; 2003; 116(3-4):134-8. PubMed ID: 12680280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer.
    Sangar VK; McBain CA; Lyons J; Ramani VA; Logue JP; Wylie JP; Clarke NW; Cowan RA
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):420-5. PubMed ID: 15667962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer.
    Caffo O; Fellin G; Graffer U; Valduga F; Bolner A; Luciani L; Tomio L; Galligioni E
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1310-6. PubMed ID: 14630267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation oncology of head and neck tumors.
    King GK; Bergman PJ; Harris D
    Vet Clin North Am Small Anim Pract; 1997 Jan; 27(1):101-13. PubMed ID: 9002170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer.
    Martenson JA; Vigliotti AP; Pitot HC; Geeraerts LH; Sargent DJ; Haddock MG; Ghosh C; Keppen MD; Fitch TR; Goldberg RM
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1305-10. PubMed ID: 12654442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for head and neck cancers.
    Gillette SM; Gillette EL
    Semin Vet Med Surg Small Anim; 1995 Aug; 10(3):168-72. PubMed ID: 8532972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant chemoradiotherapy with low-dose weekly gemcitabine for nonmetastatic unresectable pancreatic cancer.
    Atasoy BM; Dane F; Uçüncü Kefelı A; Cağlar H; Cıngı A; Turhal NS; Abacioğlu U; Yeğen C
    Turk J Gastroenterol; 2011 Feb; 22(1):60-4. PubMed ID: 21480113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study.
    Dueñas-González A; Cetina-Perez L; Lopez-Graniel C; Gonzalez-Enciso A; Gómez-Gonzalez E; Rivera-Rubi L; Montalvo-Esquivel G; Muñoz-Gonzalez D; Robles-Flores J; Vazquez-Govea E; de La Garza J; Mohar A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):817-23. PubMed ID: 15708261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.